Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Financial Resilience | Tenet Healthcare demonstrates robust financial health with a 76% stock price gain and an impressive free cash flow yield of 19%, showcasing its market strength |
Strategic Cost Control | Explore Tenet's successful management of contract labor costs, paving the way for potential capacity growth and improved margin stability in a competitive healthcare landscape |
Market Dynamics | Learn how sustained inpatient volume growth, driven by an aging population, positions Tenet for long-term success despite temporary outpatient challenges |
Analyst Perspectives | With an average price target of $173.25, analysts maintain a positive outlook on Tenet's profitability and growth potential, despite policy-related risks |
Metrics to compare | THC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTHCPeersSector | |
---|---|---|---|---|
P/E Ratio | 4.0x | 16.9x | −0.7x | |
PEG Ratio | 0.01 | 0.72 | 0.00 | |
Price/Book | 3.1x | 2.8x | 2.6x | |
Price / LTM Sales | 0.6x | 0.9x | 3.1x | |
Upside (Analyst Target) | 31.3% | 38.7% | 49.4% | |
Fair Value Upside | Unlock | 34.0% | 8.9% | Unlock |